Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3b crossover study of DE-089C vs DIQUAS for adherence in dry eye
jRCT2080225370Phase 3Completed
- Sponsor
- Santen Pharmaceutical
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of diquafosol in dry eye syndrome (DED) (2 arms), sponsored by Santen Pharmaceutical. Started Aug 2020; status: completed.
02
Drugs
diquafosol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on jRCT2080225370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225370.